Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

BI 1218.149. A 24 week randomized, double-blind, placebo-controlled, parallel group, efficacy and safety trial of once daily linagliptin, 5 milligrams orally, as added on to basal insulin in elderly type 2 diabetes mellitus patients with insufficient glycaemic control

Project: Types of projectsProject

View graph of relations

ID: 44814387